MYOZYME® 50 mg


Powder for concentrate for solution for infusion
scheduling status
S4
registration number
43/31/0745
What MYOZYME® 50 mg contains
Each vial contains 50 mg of alglucosidase alfa. After reconstitution, the solution contains 5 mg/mL alglucosidase alfa (total extractable dose of 50 mg/10 mL).
other ingredients
Mannitol Polysorbate 80 (Tween 80) Sodium phosphate dibasic heptahydrate Sodium phosphate monobasic monohydrate.
Therapeutic classification
A16AB0.
© 2026 SAHPRA. ALL RIGHTS RESERVED